News By Tag
News By Location
Follow on Google News
IQ4I research & Consultancy Published New Report on PCR Technologies (qPCR, dPCR) Global Market
IQ4I estimates the global PCR Technologies market to be worth $13.4 billion by 2020
By: IQ4I Research & Consultancy
IQ4I’s Report Contains 167 market data tables and34figures spread through 321 pages and an exhaustive TOC on “PCR Technologies Global Market [Techniques (Standard PCR, Real Time PCR/ qPCR, Reverse transcriptase PCR, Digital PCR, Assembly PCR, Multiplex PCR, Hot Start PCR, Others (Nested, Inverse, Immuno, Long PCR)), Products (Instruments, Reagents & Consumables, Software, and Services), Applications (Clinical diagnostics, Industry applications, and Others), End-Users (Hospitals and laboratories, Pharmaceuticals, CRO's and Biotech companies, Academics, and Others), Region (North America, Europe, APAC and RoW)]
Early buyers will receive 10% customization of your requirements.
The global PCR technologies global market is expected to reach $13.4 billion by 2020 and is mainly driven by factors such as booming healthcare technology market with demand for innovative technology for early and accurate diagnosis of life threatening diseases, rising investments in companion diagnostics, advent of digital PCR, expiry of key players PCR patents, increasing demand for PCR in genetic and molecular testing. However, few factors such as stringent government regulations, lack of awareness of this technology and unavailability of skilled labour, emergence of alternate technology such as Next Generation Sequencing, high cost of some of the commercial PCR’s are expected to hamper the PCR market growth.
In 2013, the North America accounted for the largest share of 43.2% in 2013. Asia-Pacific registered the highest CAGR during the forecast period. Rest of the world regions such as Middle East and North/South African countries are also expected to grow at a strong CAGR from 2014 to 2020. The majority of the growth is driven by the factors such as high unmet medical requirements in infectious and chronic disease segment such as cancer, diabetes and cardiovascular diseases and the introduction of healthcare reforms in emerging markets such as India and China, growing demand for genetic testing as an effective means to develop personalized medicine.
Major players in PCR market include Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Qiagen N.V. (Netherlands)